More about

Ocular Hypertension

News
July 25, 2024
1 min read
Save

Real-world study shows sustained effect of suprachoroidal triamcinolone in UME

Real-world study shows sustained effect of suprachoroidal triamcinolone in UME

PARK CITY, Utah — Suprachoroidal drug delivery for uveitic macular edema provides durable effects in real-world settings, matching those of phase 3 clinical trials, according to a speaker at Clinical Trials at the Summit.

News
July 20, 2024
5 min watch
Save

VIDEO: Triamcinolone acetonide an option in those with uveitic macular edema, IOP issues

VIDEO: Triamcinolone acetonide an option in those with uveitic macular edema, IOP issues

In this Healio Video Perspective from the ASRS meeting, Danny Mammo, MD, of Cole Eye Institute discusses the real-world effect of triamcinolone acetonide on IOP in patients with uveitic macular edema.

News
June 27, 2024
1 min read
Save

Novel implants show promise in drug delivery

Novel implants show promise in drug delivery

KIAWAH ISLAND, S.C. — Drug-eluting implants in various stages of study and approval may provide efficient, sustained drug delivery, overcoming barriers to penetration, according to a speaker at Kiawah Eye.

News
May 07, 2024
1 min read
Save

Qlaris raises $24 million for development of IOP-lowering therapy

Qlaris raises $24 million for development of IOP-lowering therapy

Qlaris Bio raised $24 million during series B financing for the clinical development of QLS-111, a new IOP-lowering drug candidate for patients with glaucoma, the company announced in a press release.

News
April 22, 2024
1 min read
Save

Sustained-release bimatoprost implant shows safety, efficacy in early study

Sustained-release bimatoprost implant shows safety, efficacy in early study

BOSTON — A sustained-release bimatoprost drug delivery platform shows promise in the treatment of ocular hypertension and open-angle glaucoma, according to a poster at the American Society of Cataract and Refractive Surgery meeting.

News
April 16, 2024
1 min read
Save

Phaco plus MIGS helps improve quality of life, prevent visual field loss

Phaco plus MIGS helps improve quality of life, prevent visual field loss

BOSTON — Phacoemulsification plus minimally invasive glaucoma surgery improves quality of life and prevents visual field loss in patients with glaucoma, according to a speaker.

News
April 03, 2024
1 min read
Save

Qlaris Bio initiates trials for potassium channel modulator therapy in glaucoma patients

Qlaris Bio initiates trials for potassium channel modulator therapy in glaucoma patients

Qlaris Bio announced the initiation and dosing of two phase 2 trials aimed at assessing QLS-111, a therapy for lowering intraocular pressure by targeting episcleral venous pressure, or EVP, in patients with glaucoma.

News
March 27, 2024
1 min read
Save

Timolol microdrops appear as effective as conventional drops in lowering IOP

Timolol microdrops appear as effective as conventional drops in lowering IOP

Timolol maleate 0.5% microdrops delivered with the Nanodropper Adaptor met three noninferiority endpoints in lowering IOP compared with conventional timolol drops, according to a study.

News
March 06, 2024
2 min watch
Save

VIDEO: Iyuzeh reduces risk of inducing dry eye when treating glaucoma

VIDEO: Iyuzeh reduces risk of inducing dry eye when treating glaucoma

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Renee Bovelle, MD, discusses the benefits of using Iyuzeh to treat glaucoma while not inducing dry eye.

News
March 05, 2024
2 min read
Save

Travoprost implant shows ‘robust’ IOP reduction at 3 months

Travoprost implant shows ‘robust’ IOP reduction at 3 months

The travoprost intraocular implant demonstrated a reduction in IOP in patients with open-angle glaucoma or ocular hypertension 3 months after a single administration, according to a study published in Ophthalmology.

View more